Chikungunya disease among infants in French West Indies during the 2014 outbreak

A Gavotto1, B Muanza2, F Delion2

  • 1Pediatric emergency, University Hospital, Pointe-à-Pitre, Guadeloupe; Pediatric and Congenital Cardiology Department, M3C Regional Center, University Hospital, Physiology and Experimental Biology of Heart and Muscles Laboratory - PHYMEDEXP, UMR CNRS 9214-INSERM U1046, Montpellier, France.

Insights

Chikungunya disease in infants presents with fever, pain, and limb swelling. Key lab findings include lymphopenia and no thrombocytopenia, aiding diagnosis in young children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Chikungunya virus (CHIKV) infection can cause significant morbidity in infants.
  • Limited data exists on the specific clinical and laboratory manifestations of CHIKV in this age group.

Purpose of the Study:

  • To characterize the clinical and laboratory features of Chikungunya disease in infants aged 1 month to 2 years.
  • To identify diagnostic indicators for Chikungunya in infants.

Main Methods:

  • Prospective epidemiologic study conducted at a university hospital.
  • Data collected from 154 infants hospitalized with Chikungunya disease between May and September 2014.

Main Results:

  • Common symptoms included hyperthermia (2.7 days), pain (82%), loss of appetite (62%), and rash (69%).
  • Edema of hands/feet (48%) and febrile seizures (12%) were observed.
  • Frequent laboratory findings were lymphopenia (94%) and monocytosis; thrombocytopenia was absent.

Conclusions:

  • Chikungunya in infants often presents with fever, pain, tachycardia, and limb edema.
  • Lymphopenia and absence of thrombocytopenia are significant diagnostic markers.
Abstract

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
498
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
263
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
987
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
480
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K